M1 Confirmation of Maternal Eligibility Primary Dataset in A Prospective, Observational Study of HIV-Infected Pregnant Women and Their Infants at Clinical Sites in Latin American and Caribbean Countries

Maternal eligibility data, participant identifier (PID) if previously enrolled in Perinatal study, estimated delivery date, current gestational age, willingness to deliver at participating clinical site, willingness for mother and child to be followed for 6 months, signed consent, and whether multiple births are expected (Confirmation of Maternal Eligibility CRF)
Study Description
Describes the characteristics of HIV-infected pregnant women and their HIV-exposed infants at participating clinical sites in Latin America and the Caribbean, including the utilization of interventions related to decreasing the risk of mother-to-child transmission. Biospecimens are available for request through DASH. Please navigate to Explore Biospecimens at the top of this page. HIV-infected women and their HIV-exposed infants

孕产妇资格相关数据：包括受试者标识符（PID，若此前已参与围产期研究（Perinatal study））、预计分娩日期、当前孕周、是否愿意在合作临床机构分娩、是否愿意配合母婴双方接受6个月随访、已签署的知情同意书，以及是否预计为多胎妊娠（孕产妇资格确认病例报告表（Confirmation of Maternal Eligibility CRF））。

研究概况
本数据集描述了拉丁美洲及加勒比地区合作临床机构中，人类免疫缺陷病毒（HIV）感染孕产妇及其HIV暴露婴儿的特征，涵盖与降低母婴传播风险相关的干预措施的应用情况。可通过DASH申请获取生物样本，请点击本页面顶部的"探索生物样本（Explore Biospecimens）"栏目进行操作。

感染HIV的孕产妇及其HIV暴露婴儿